Inactivation of<scp>M</scp>iddle<scp>E</scp>ast respiratory syndrome coronavirus (<scp>MERS‐C</scp>o<scp>V</scp>) in plasma products using a riboflavin‐based and ultraviolet light‐based photochemical treatment

Riboflavin and UV light effectively reduced the titer of MERS-CoV in human plasma products to below the limit of detection, suggesting that the treatment process may reduce the risk of transfusion transmission of MERS-CoV.